David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 18,294 shares at $6.43 ($118K) on 2020-02-25, disclosed to the SEC on 2020-02-28.
Open-market sale of $118k STML by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.43 | 9,147 | $59K | 50.0% |
| 2 | $6.43 | 9,147 | $59K | 50.0% |
| Total | $6.43 avg | 18,294 | $118K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |
| STML | SELL | 2019-03-15 | $306K | — | Filing → |